Canadian-based Intronix Technologies will be working with Roy Eagleson, Ph.D., professor in the Department of Biomedical Engineering and Software Engineering at Western University, to develop new medical simulations to support treatment delivery to patients with musculoskeletal disorders.
Konica Minolta will highlight its Exa Enterprise Imaging platform at the 2017 annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.
Provision, located in Knoxville, Tenn., is the latest to partner with RaySearch Laboratories on the development of its next-generation oncology information system (OIS), RayCare.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Augmenix Inc. announced that the National Institute for Health and Care Excellence (NICE) in the U.K. has issued Interventional Procedure Guidance (IPG) supporting the use of a hydrogel barrier to reduce the risk of toxicity to surrounding tissue in radiotherapy to treat prostate cancer. The guidance recommends use of hydrogel spacers under "standard arrangements". For a procedure to be recommended for use with standard arrangements (previously called “normal arrangements”), the evidence should be adequate to show safety and efficacy of the procedure both in the long term and short term. NICE’s guidance clearly indicates that this procedure meets the highest evidence standards.
Endovascular simulation solution provider Mentice announced the release of a new simulation training software for transarterial chemoembolization (TACE). The new software will be showcased at the 2017 Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Congress, to be held Sept. 16-20 in Copenhagen, Denmark.

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
September 8, 2017 — Delphinus Medical Technologies Inc. announced that the SoftVue Discover Breast Ultrasound ...
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
September 8, 2017 — Fujifilm Medical Systems U.S.A. Inc. recently introduced support for DICOM web services, including ...
The new Visicoil MR is a helically-wound, flexible linear fiducial marker. The Visicoil MR hollow core design and ...
Last year, our health system ranked dead last among those of 11 developed nations (including France, Germany, Great Britain and Canada) in calculations done by the Commonwealth Fund, a private foundation that specializes in the analysis of healthcare. This despite seven years of expanded access to healthcare through the Affordable Care Act, also known as “Obamacare.”
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
Edward Hospital & Health Services is a full-service, regional healthcare provider offering sophisticated medical specialties. It is located in the western suburbs of Chicago, with two main campuses in Naperville and Plainfield, plus outpatient facilities and physician offices throughout the region.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with dense breast tissue. Both dense breast tissue and cancer cells can appear as solid white in mammography, increasing the risk that results might be misinterpreted. Some recent advances in both technology and in communications about breast density have the potential to help clinicians and patients overcome these challenges in the years ahead.
By definition, distributed radiology, or Teleradiology 3.0, is the progressive step in transforming mutual exclusivity of onsite radiology practice and teleradiology outsourcing into a seamless radiology distribution model. By extending deeply into acute and ambulatory health systems, distributed radiology utilizes data fluidity to provide rapid diagnostic interpretation regardless of exam origin or physician location.
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
As one of the more precise methods of delivering radiation therapy for cancer treatment, proton therapy has grown at a rapid pace the last several years. Considered experimental not too long ago and used primarily in research settings, clinicians across the globe are rapidly coming to accept the utility of proton therapy for numerous indications — a list that many expect to continue to grow rapidly.
Continuing education and training are essential in the healthcare industry. Physicians are required to earn a certain number of continuing medical education credits to maintain license registration, and radiologic technologists must earn a certain number of continuing education credits to maintain American Registry of Radiologic Technologists (ARRT) certification and registration.
Cancer is perhaps the most highly personal, complex disease in our world today. While the various types of cancer are ...
University Medical Center Groningen (UMCG) is one of the largest hospitals in the Netherlands. The hospital provides world-class patient care and is engaged in cutting-edge scientific research and medical education. UMCG is a leading cancer center and will soon open a new state-of-the-art proton therapy center.
The ITN team recently attended the Association for Medical Imaging Management (AHRA)’s 45th Annual Meeting and Exposition in Anaheim, Calif., where nearly 1,000 members, vendors and presenters came together to learn and network. We learned from the three nationally renowned keynote speakers, more than 100 breakout sessions and from the new technology showcased in the exhibit hall by 160 different companies.
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology and has prompted the implementation of radiation dose monitoring systems. Prior to these systems, dose measurements either were not tracked or required manual calculation of dose based on scanner data in the DICOM headers.
September 7, 2017 — Sapheneia and Scannerside received U.S. Food and Drug Administration (FDA) 510(k) clearance to ...
The U.S. Food and Drug Administration (FDA) announced it would hold a meeting of the Medical Imaging Drugs Advisory Committee (MIDAC) on Sept. 8 to discuss regulatory approaches for use of gadolinium-based contrast agents (GBCAs).